{"entity":{"id":"int-milan","kind":"institution","name":"Fondazione IRCCS Istituto Nazionale dei Tumori","aka":[],"tldr":"The Istituto Nazionale dei Tumori is Italy's national cancer institute and a leader in sarcoma, thoracic oncology, and immunotherapy.","summary":"Fondazione IRCCS Istituto Nazionale dei Tumori in Milan is Italy's national cancer institute and ranks twenty-seventh in the Newsweek/Statista oncology list. It is a sarcoma reference centre, with Alessandro Gronchi, Silvia Stacchiotti and Filippo de Braud among its clinicians, and it leads in peritoneal surface malignancy through HIPEC and PIPAC intraperitoneal chemotherapy, alongside thoracic oncology, immunotherapy and early-phase trials. OnCo links it to sarcomas of soft tissue, bone and GIST, to Fondazione AIRC, and to fellow IRCCS institutes San Raffaele and Regina Elena. Whether intraperitoneal chemotherapy earns its place against systemic treatment in randomised trials is the open question its surgical programme faces. Its sarcoma programme is the reason most readers come.","asOf":"2026-09-04","wikipedia":"https://en.wikipedia.org/wiki/Istituto_Nazionale_dei_Tumori","links":[{"label":"Official website","url":"https://www.istitutotumori.mi.it"}],"tags":[],"related":[],"cancers":["sarcoma"],"sections":[],"technologies":["hipec"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["filippo-de-braud","silvia-stacchiotti","alessandro-gronchi","marco-guzzo","gustavo-galmozzi"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Milan","country":"IT","lat":45.479,"lng":9.213,"institutionType":"cancer-center","website":"https://www.istitutotumori.mi.it","newsweekOncology2026":27,"programs":["Sarcoma","Peritoneal surface malignancy"]},"route":"/institutions/int-milan/","neighbours":{"cancer":[{"id":"sarcoma","kind":"cancer","name":"Sarcomas (soft tissue, bone, GIST)","route":"/cancers/sarcoma/"}],"technology":[{"id":"hipec","kind":"technology","name":"HIPEC / PIPAC (intraperitoneal chemotherapy)","route":"/technologies/hipec/"}],"person":[{"id":"alessandro-gronchi","kind":"person","name":"Alessandro Gronchi","route":"/people/alessandro-gronchi/"},{"id":"filippo-de-braud","kind":"person","name":"Filippo de Braud","route":"/people/filippo-de-braud/"},{"id":"gustavo-galmozzi","kind":"person","name":"Gustavo Galmozzi","route":"/people/gustavo-galmozzi/"},{"id":"marco-guzzo","kind":"person","name":"Marco Guzzo","route":"/people/marco-guzzo/"},{"id":"silvia-stacchiotti","kind":"person","name":"Silvia Stacchiotti","route":"/people/silvia-stacchiotti/"}],"institution":[{"id":"airc","kind":"institution","name":"Fondazione AIRC per la ricerca sul cancro","route":"/institutions/airc/"},{"id":"fondazione-michelangelo","kind":"institution","name":"Fondazione Michelangelo","route":"/institutions/fondazione-michelangelo/"},{"id":"fondazione-the-bridge","kind":"institution","name":"Fondazione The Bridge","route":"/institutions/fondazione-the-bridge/"},{"id":"san-raffaele","kind":"institution","name":"IRCCS Ospedale San Raffaele","route":"/institutions/san-raffaele/"},{"id":"regina-elena-rome","kind":"institution","name":"IRCCS Regina Elena National Cancer Institute","route":"/institutions/regina-elena-rome/"}],"company":[{"id":"italian-sarcoma-group","kind":"company","name":"Italian Sarcoma Group","route":"/companies/italian-sarcoma-group/"}]}}